1. All Products
  2. D - Drugs
  3. LACTULOSE, min. 3.1g/5ml, oral sol., bot.
Public Pricelist

LACTULOSE, min. 3.1g/5ml, oral sol., bot.

https://medicalguidelines.msf.org/en/node/427
https://unicat.msf.org/cat/product/12110
STD DORALACT1S-

Valid Article

Former Code(s): -X
2.3 - Medicines for other common symptoms in palliative care
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
A06AD11
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://unicat.msf.org/web/image/product.template/572465/image_1920?unique=1c01e1b

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

LACTULOSE

Therapeutic Action

Osmotic laxative

Indications

Prevention of opioid-induced constipation (codeine, morphine, etc.)

Instructions for use

To prevent opioid-induced constipation, use lactulose if stools are solid or bisacodyl if stools are soft.

Advice on diet should accompany treatment.

Storage

  • Below 25°C
  • Do not refrigerate (crystallisation). Do not freeze.